Ozark Health Ventures, LLC dba Cancer Research for the Ozarks

描述(由申请人提供)：20多年来，欧扎克癌症研究中心(CRO)为密苏里州西南部及周边地区的农村社区提供了NCI批准的临床试验。通过医学博士温德尔·古德温和医学博士罗伯特·L·卡罗拉等富有远见的领导，原本无法参加临床试验的患者可以选择参加社区临床肿瘤学计划。 从一开始，CRO就得到了两个国家公认的医疗保健系统的支持，即密苏里州斯普林菲尔德的考克斯健康系统和圣约翰健康系统。后来又增加了两家Joplin附属公司，CRO现在提供该地区95%以上的癌症护理资源，包括由肿瘤学家、放射肿瘤学家、妇科肿瘤学家、泌尿科医生、外科医生和初级保健专家组成的医生网络。 CRO支持CCOP的使命，即通过增加试验收益来加速开发预防和治疗癌症的干预措施。CRO的患者参与率超过5%，在过去五年中，每年都有200多名患者参加治疗和预防控制试验。CRO的33名医生调查人员积极参与该计划，提高人们对治疗、控制和预防方面的最新发展以及社区整体护理质量的认识。CRO还成功地增加了少数族裔的参与，他们登记的比例高于普通癌症人口。

DESCRIPTION (provided by applicant): For over 20 years, Cancer Research for the Ozarks (CRO) has provided NCI-approved clinical trials to the rural communities of Southwestern Missouri and surrounding areas. Through the visionary leadership of physicians such as Wendall Goodwin, MD and Robert L. Carolla, MD, patients who otherwise would not have access to clinical trials can elect to participate through the Community Clinical Oncology Program. From its inception, CRO has had the support of the two nationally recognized health care systems, Cox Health and St. John's Health System in Springfield, Missouri. With the later addition of two Joplin affiliates, CRO now provides more than 95 percent of cancer care resources in the area including a physician network of oncologists, radiation oncologists, gynecological oncologists, urologists, surgeons, and primary care specialists. CRO supports the CCOP mission of accelerating development of interventions to prevent and treat cancer by increasing accruals to trials. CRO exceeds five percent patient participation with over 200 patients enrolled to treatment and prevention and control trials each of the past five years. CRO's thirty-three physician investigators actively participate in the program increasing awareness of recent developments in treatment, control and prevention and the overall quality of care in the community. CRO has also successfully increased involvement of minorities enrolling a higher percentage than that of the general cancer population.